Literature DB >> 9246034

Gain of chromosome 20 is a frequent aberration in liver metastasis of colorectal cancers.

A Nanashima1, H Yamaguchi, T Yasutake, T Sawai, H Kusano, Y Tagawa, T Nakagoe, H Ayabe.   

Abstract

To investigate the characteristics of the numerical chromosome aberrations in liver metastasis of colorectal cancers, fluorescence in situ hybridization (FISH) for chromosomes 8, 18, 14/22, and 20 was performed in 18 specimens of primary regions and 18 of metastatic regions in liver metastasis of colorectal cancers compared with 15 of non-liver metastatic cancers. Among these numerical aberrations, the gain of chromosome 20, especially copy numbers exceeding three, was frequently observed in primary and metastatic cancers. Among these numerical aberrations, the gain of chromosome 20, especially copy numbers exceeding three, was frequently observed in primary and metastatic regions of liver metastasis groups compared with that of the non-liver metastasis group (P < 0.05). The incidences of gain of chromosome 20 in both regions of the liver metastasis group were higher than that of the non-liver metastasis group (P < 0.05). The gain of chromosome 20 is a frequent aberration in primary and metastatic regions in patients with liver metastatic colorectal cancers and may be available as a genetic marker for the diagnosis or prediction of liver metastasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246034     DOI: 10.1023/a:1018885803931

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics.

Authors:  D W Visscher; T L Wallis; J D Crissman
Journal:  Cancer       Date:  1996-01-15       Impact factor: 6.860

2.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

3.  Human gene for proliferating cell nuclear antigen has pseudogenes and localizes to chromosome 20.

Authors:  D H Ku; S Travali; B Calabretta; K Huebner; R Baserga
Journal:  Somat Cell Mol Genet       Date:  1989-07

4.  Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP).

Authors:  S Ichii; S Takeda; A Horii; S Nakatsuru; Y Miyoshi; M Emi; Y Fujiwara; K Koyama; J Furuyama; J Utsunomiya
Journal:  Oncogene       Date:  1993-09       Impact factor: 9.867

5.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

6.  Comparative genomic in situ hybridization of colon carcinomas with replication error.

Authors:  J Schlegel; G Stumm; H Scherthan; T Bocker; H Zirngibl; J Rüschoff; F Hofstädter
Journal:  Cancer Res       Date:  1995-12-15       Impact factor: 12.701

7.  Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer.

Authors:  Y J Guo; G Liu; X Wang; D Jin; M Wu; J Ma; M S Sy
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

8.  Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications.

Authors:  M M Tanner; M Tirkkonen; A Kallioniemi; K Holli; C Collins; D Kowbel; J W Gray; O P Kallioniemi; J Isola
Journal:  Clin Cancer Res       Date:  1995-12       Impact factor: 12.531

Review 9.  The chromosomal analysis of human solid tumors. A triple challenge.

Authors:  J R Teyssier
Journal:  Cancer Genet Cytogenet       Date:  1989-01

10.  Changes in the nuclear distribution of cyclin (PCNA) but not its synthesis depend on DNA replication.

Authors:  R Bravo; H Macdonald-Bravo
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

View more
  9 in total

1.  Gene array and fluorescence in situ hybridization biomarkers of activity of saracatinib (AZD0530), a Src inhibitor, in a preclinical model of colorectal cancer.

Authors:  John J Arcaroli; Basel M Touban; Aik Choon Tan; Marileila Varella-Garcia; Rebecca W Powell; S Gail Eckhardt; Paul Elvin; Dexiang Gao; Wells A Messersmith
Journal:  Clin Cancer Res       Date:  2010-08-03       Impact factor: 12.531

Review 2.  Chromosomal aberrations related to metastasis of human solid tumors.

Authors:  Lun-Xiu Qin
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

3.  Prognostic factors in hepatic metastases of colorectal carcinoma: immunohistochemical analysis of tumor biological factors.

Authors:  A Nanashima; H Yamaguchi; T Sawai; E Yamaguchi; H Kidogawa; S Matsuo; T Yasutake; T Tsuji; M Jibiki; T Nakagoe; H Ayabe
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

4.  Cytogenetic analyses of secondary liver tumors reveal significant differences in genomic imbalances between primary and metastatic colon carcinomas.

Authors:  L A Parada; A Marañon; M Hallén; K G Tranberg; U Stenram; G Bardi; B Johansson
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

5.  Significance of angiogenic factors in liver metastatic tumors originating from colorectal cancers.

Authors:  A Nanashima; M Ito; I Sekine; S Naito; H Yamaguchi; T Nakagoe; H Ayabe
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

Review 6.  The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review.

Authors:  A A P Slesser; P Georgiou; G Brown; S Mudan; R Goldin; P Tekkis
Journal:  Clin Exp Metastasis       Date:  2012-11-23       Impact factor: 5.150

7.  Specific genomic aberrations in primary colorectal cancer are associated with liver metastases.

Authors:  Sjoerd C Bruin; Christiaan Klijn; Gerrit-Jan Liefers; Linde M Braaf; Simon A Joosse; Eric H van Beers; Victor J Verwaal; Hans Morreau; Lodewyk F Wessels; Marie-Louise F van Velthuysen; Rob A E M Tollenaar; Laura J Van't Veer
Journal:  BMC Cancer       Date:  2010-12-02       Impact factor: 4.430

8.  Molecular alterations associated with liver metastases development in colorectal cancer patients.

Authors:  S C Bruin; Y He; I Mikolajewska-Hanclich; G-J Liefers; C Klijn; A Vincent; V J Verwaal; K A de Groot; H Morreau; M-L F van Velthuysen; R A E M Tollenaar; L J van 't Veer
Journal:  Br J Cancer       Date:  2011-06-14       Impact factor: 7.640

9.  Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer.

Authors:  Jialing Zhang; Bin Yan; Stephan Stanislaw Späth; Hu Qun; Shaleeka Cornelius; Daogang Guan; Jiaofang Shao; Koichi Hagiwara; Carter Van Waes; Zhong Chen; Xiulan Su; Yongyi Bi
Journal:  Cell Biosci       Date:  2015-09-17       Impact factor: 7.133

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.